naloxone and AIDS-Dementia-Complex

naloxone has been researched along with AIDS-Dementia-Complex* in 2 studies

Other Studies

2 other study(ies) available for naloxone and AIDS-Dementia-Complex

ArticleYear
A central role for glial CCR5 in directing the neuropathological interactions of HIV-1 Tat and opiates.
    Journal of neuroinflammation, 2018, Oct-10, Volume: 15, Issue:1

    The collective cognitive and motor deficits known as HIV-associated neurocognitive disorders (HAND) remain high even among HIV+ individuals whose antiretroviral therapy is optimized. HAND is worsened in the context of opiate abuse. The mechanism of exacerbation remains unclear but likely involves chronic immune activation of glial cells resulting from persistent, low-level exposure to the virus and viral proteins. We tested whether signaling through C-C chemokine receptor type 5 (CCR5) contributes to neurotoxic interactions between HIV-1 transactivator of transcription (Tat) and opiates and explored potential mechanisms.. Neuronal survival was tracked in neuronal and glial co-cultures over 72 h of treatment with HIV-1 Tat ± morphine using cells from CCR5-deficient and wild-type mice exposed to the CCR5 antagonist maraviroc or exogenously-added BDNF (analyzed by repeated measures ANOVA). Intracellular calcium changes in response to Tat ± morphine ± maraviroc were assessed by ratiometric Fura-2 imaging (analyzed by repeated measures ANOVA). Release of brain-derived neurotrophic factor (BDNF) and its precursor proBDNF from CCR5-deficient and wild-type glia was measured by ELISA (analyzed by two-way ANOVA). Levels of CCR5 and μ-opioid receptor (MOR) were measured by immunoblotting (analyzed by Student's t test).. Our results suggest a critical role for glial CCR5 in mediating neurotoxic effects of HIV-1 Tat and morphine interactions on neurons. A shift in the proBDNF/BDNF ratio that favors neurotrophic support may occur when glial CCR5 signaling is blocked. Some neuroprotection occurred only in the presence of morphine, suggesting that loss of CCR5 may fundamentally change signaling through the MOR in glia.

    Topics: AIDS Dementia Complex; Analgesics, Opioid; Animals; CCR5 Receptor Antagonists; Corpus Striatum; Cytokines; Disease Models, Animal; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Maraviroc; Mice; Mice, Inbred C57BL; Mice, Transgenic; Naloxone; Narcotic Antagonists; Neuroglia; Neurons; Opiate Alkaloids; Receptors, CCR5; Receptors, Opioid, mu; tat Gene Products, Human Immunodeficiency Virus

2018
Morphine exacerbates HIV-1 viral protein gp120 induced modulation of chemokine gene expression in U373 astrocytoma cells.
    Current HIV research, 2005, Volume: 3, Issue:3

    HIV-1 affects microglia and astroglia, which subsequently contributes to the neurodegenerative changes. Viral proteins cause neurotoxicity by direct action on the CNS cells or by activating glial cells to cause the release of cytokines, chemokines or neurotoxic substances. Opioid abuse has been postulated as a cofactor in the immunopathogenesis of human immunodeficiency virus (HIV) infection and AIDS. HIV-induced pathogenesis is exacerbated by opiate abuse and that the synergistic neurotoxicity is a direct effect of opiates on the CNS. Chemokines and their receptors have been implicated in the pathogenesis of neuroAIDS. Herein we describe the effects of morphine and/or gp120 on the expression of the genes for the beta-chemokine MIP-1beta and its receptors CCR3 and CCR5 by the U373 cells which are a human brain-derived astrocytoma/glioblastoma cell line. Our results indicate that treatment of U373 cells with morphine significantly downregulated the gene expression of the beta chemokine, MIP-1 beta, while reciprocally upregulating the expression of its specific receptors, CCR3 and CCR5 suggesting that the capacity of mu-opioids to increase HIV-1 co-receptor expression may promote viral binding, trafficking of HIV-1-infected cells, and enhanced disease progression. Additionally, opiates can enhance the cytotoxicity of HIV-1 viral protein gp120 via mechanisms that involve intracellular calcium modulation resulting in direct actions on astroglia, making them an important cellular target for HIV-opiate interactions.

    Topics: AIDS Dementia Complex; Astrocytes; Calcium; Cell Line, Tumor; Chemokine CCL4; Chemokines; Gene Expression; HIV Envelope Protein gp120; HIV Infections; HIV-1; Humans; Immunologic Factors; In Vitro Techniques; Macrophage Inflammatory Proteins; Morphine; Naloxone; Narcotic Antagonists; Receptors, CCR3; Receptors, CCR5; Receptors, Chemokine; Receptors, Opioid, mu

2005